DCTH — Delcath Systems Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Delcath Systems Inc

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$10.95
Market Cap$388M
Float28.6M
Shares Outstanding34.5M
P/E (Forward)25.77
P/E (TTM)1,123.00
Price/Sales (TTM)4.29
vs. Analyst Target+94.5% to analyst PT
Profit Margin0.62%
Operating Margin (TTM)-6.55%
Revenue (TTM)$90.4M
Earnings Growth (YoY)-66.70%
Dividend RateNone
Analyst Target Price$21.29 (6 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $1.6M -$24.2M $1.0M -$23.8M
2021 $3.6M -$25.6M $2.9M -$24.3M
2022 $2.7M -$36.5M $2.0M -$33.7M
2023 $2.1M -$47.7M $1.4M -$37.8M
2024 $37.2M -$26.4M $31.0M -$12.2M
2025 $85.2M $2.7M $73.4M $3.9M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $24.2M $2.7M
Sep 2025 $20.6M $830,000
Dec 2025 $20.7M -$1.9M
Mar 2026 $25.0M -$1.1M

Ownership & Float

Insider Ownership8.1%
Institutional Ownership48.8%
Short Float12.4%
% of All Funds Holding1.31%
Number of Funds Holding108

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$10.57Near-term / short-term trend
Weekly40-Week SMA$10.20Medium-term trend
Weekly80-Week SMA$11.63Cyclical trend (business cycle)
Weekly200-Week SMA$7.87Secular trend (multi-year)
Monthly10-Month SMA$10.08Near-term monthly trend
Monthly20-Month SMA$11.54Medium-term monthly trend
Monthly40-Month SMA$8.68Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$13.50 resistance 1.54x 9 months ago
$16.20 resistance 1.62x 10 months ago
$8.70 support 1.28x 20 months ago

Historical Earnings Reactions (33 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.70% 0.00% 48.48% 11.29% -4.35%
1 Day -0.10% 0.00% 45.45% 23.27% -24.50%
1 Week 5.12% 0.49% 51.52% 63.33% -13.24%
2 Weeks 3.90% -1.80% 36.36% 46.57% -20.49%
1 Month 3.30% 5.13% 56.25% 81.56% -65.45%

Next earnings: July 26, 2026 (57 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-1.5%50.0%8
Feb-2.4%25.0%8
Mar-2.8%37.5%8
Apr-2.0%37.5%8
May4.4%42.9%7
Jun0.0%37.5%8
Jul-11.2%37.5%8
Aug9.3%75.0%8
Sep-9.3%12.5%8
Oct-13.1%25.0%8
Nov-6.4%25.0%8
Dec3.3%62.5%8

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.09% 43.7% 380
Tuesday 0.56% 44.7% 418
Wednesday -0.42% 42.4% 413
Thursday -0.45% 42.6% 406
Friday 0.45% 45.6% 408

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 48.8%

Insider Transactions — Smart Summary

Total insider ownership: 8.1%

12-Month Insider Activity Summary

Total Filings4
Net Value+$248,376.76
Net Shares Change32,619
% of Float0.1%
C-Suite Filings3
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
MICHEL GERARD J CHIEF EXECUTIVE OFFICER +$198,358.44 2 2 buy
Pennell Sandra Chief Financial Officer +$50,018.32 1 1 buy
Sylvester John Richard +$38,991.54 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-06 Pennell Sandra Chief Financial Officer +$50,018.32 Transaction at $9.04, now +21.1%
2026-03-03 MICHEL GERARD J CHIEF EXECUTIVE OFFICER +$100,309.44 Transaction at $8.96, now +22.3%
2025-11-13 MICHEL GERARD J CHIEF EXECUTIVE OFFICER +$98,049 Transaction at $8.53, now +28.4%
2025-11-25 Sylvester John Richard +$38,991.54 Transaction at $8.89, now +23.2%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Delcath Systems Inc (DCTH) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for DCTH on Trend Edge →